Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus

A key objective in the use of immunosuppression after kidney transplantation is to attain the optimal balance between efficacy and safety. In a phase 3b, multicenter, randomized, open-label, noninferiority study, the incidences of clinical events, renal dysfunction, and adverse events (AEs) were ana...

詳細記述

保存先:
書誌詳細
主要な著者: Fuad S. Shihab, Y. Qazi, S. Mulgaonkar, Kevin McCague, Dharmesh Patel, V.R. Peddi, David R. Shaffer
フォーマット: Artigo
言語:英語
出版事項: 2017
オンライン・アクセス:https://doi.org/10.1111/ajt.14215
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ajt.14215
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!